One of DMTC's newest programs, Medical Countermeasures (MCM) is quickly being identified as a key capability to protect both the military and the public from chemical, biological and radiological (CBR) threats, as well as pandemics and emerging infectious diseases. Funded by CSIRO and DST Group through the next Generation Technologies Fund, DMTC is seeking to harness Australia's capabilities to develop leading-edge, advanced technologies and to direct and deploy skills into activities that support Australia